Oncology, rare diseases and too little genomic diversity: 3 themes from #JPM17

As always, the J.P. Morgan Healthcare Conference played host to wider debates about the health and direction of the life sciences in 2017.

Drug pricing was part of the discussion (Trump made his splash mid-week). Gender diversity came to the fore in 2016 and made headways at this year’s event.

Beyond the conference agenda and the breaking news, however, three underground themes were playing out at Bioweek.